Pyrido(3,2-d)pyrimidine derivatives represented by the structural formuia (Ia): wherein, R1, R2 and R3 are defined herein, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro-drugs thereof, for use in the treatment of hepatitis C.
Pyrido(3,2-d)pyrimidine衍
生物由结构式(Ia)表示:其中,R1、R2和R3在此处定义,其药用可接受的盐、立体
化学异构体形式、N-氧化物、溶剂合物及其前药,用于治疗丙型肝炎。